PATENTS RELATED TO <I>NEISSERIA</I>

Professor Demchick's Patent Services

Paul H. Demchick, United States Registered Patent Agent
(United States Patent and Trademark Office Registration 52,808)

PATENTS RELATED TO NEISSERIA

Although Dr. Demchick also represents patent seekers with non-microbiological inventions, his doctorate is in microbiology. Microbiology has been the primary focus of his research and teaching. He especially loves dealing with patent searches and applications for involving microbiology.

Dr. Demchick is a scientist with a quarter of a century of research experience in academic, industrial and governmental settings.
If you are considering patent protection for an invention, Dr. Demchick will be glad to discuss the matter with you. There is no charge for an initial discussion.
The following sampling is to give you some sense of the types of Neisseria related inventions which have received United States patent protection. The patent list is not exhaustive and is certainly not a substitute for a proper patent search . It should be noted that only U.S. Patents are included.
It should be noted that spelling, form and typographical errors in the original patents are preserved here.

Neisseria lactoferrin binding protein (United States Patent 7,105,316)
Method of treating subject infected with Neisseria gonorrhea (United States Patent 7,094,809)
Polynucleotides and polypeptides BASB033 from Neisseria meningitidis and their uses (United States Patent 7,071,321)
Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes (United States Patent 7,063,949)
Method of inhibiting formation of Neisseria gonorrhea and Neisseria meningiditis (United States Patent 7,037,945)
DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses (United States Patent 7,029,845)
Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies (United States Patent 6,994,860)
Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis (United States Patent 6,936,261)
Monoclonal antibody to the stabilizer peptide of the P64K antigen of Neisseria meningitidis (United States Patent 6,921,809)
Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria (United States Patent 6,861,507)
Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains (United States Patent 6,835,384)
Neisseria meningitidis antigen (United States Patent 6,797,273)
Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis (United States Patent 6,780,419)
Polypeptides and polynucleotides BASB040 from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides (United States Patent 6,770,284)
BASB013 DNA and proteins from Neisseria meningitidis (United States Patent 6,709,657)
BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof (United States Patent 6,696,062)
Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof (United States Patent 6,693,186)
Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes (United States Patent 6,642,354)
Neisseria meningitidis serogroup B Glycoconjugates (United States Patent 6,638,513)
Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses (United States Patent 6,627,204)
Nucleic acid molecules encoding proteins which impart the adhesion of neisseria cells to human cells (United States Patent 6,617,128)
OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof (United States Patent 6,610,306)
Hybridization assay probes and methods for detecting the presence of neisseria meningitiidis subtypes A, C and L in a sample (United States Patent 6,541,201)
Conjugate vaccine for Neisseria meningitidis (United States Patent 6,531,131)
Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus (United States Patent 6,497,880)
Invasion associated genes from Neisseria meningitidis serogroup B (United States Patent 6,472,518)
Transferrin receptor subunit proteins of Neisseria meningitidis (United States Patent 6,326,350)
Proteinase K resistant surface protein of neisseria meningitidis (United States Patent 6,287,574)
PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis (United States Patent 6,169,169)
Nucleic acid probes and amplification oligonucleotides for Neisseria species (United States Patent 6,100,027)
Neisseria gonorrhoeae-specific oligonucleotides (United States Patent 6,090,557)
Neisseria meningitidis capsular polysacchride conjugates (United States Patent 6,080,589)
Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis (United States Patent 6,028,049)
Hexapeptides of Neisseria gonorrhoeae (United States Patent 6,020,461)
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis (United States Patent 6,013,267)
Neisseria gonorrhoeae specific DNA fragment--GC3 (United States Patent 5,976,805)
Neisseria mutants, lipooligosaccharides and immunogenic compositions (United States Patent 5,976,536)
Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases (United States Patent 5,965,424)
Detection of Neisseria gonorrhoeae by amplification and detection of its nucleic acid (United States Patent 5,962,273)
Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified state (United States Patent 5,928,650)
Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis (United States Patent 5,912,336)
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis (United States Patent 5,879,686)
Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin (United States Patent 5,834,591)
Method of differentiating pelvic inflamatory disease and local isolates of Neisseria gonorrhoeae (United States Patent 5,824,480)
Neisseria meningitidis capsular polysaccharide conjugates (United States Patent 5,780,606)
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis (United States Patent 5,747,287)
Nucleic acid probes and amplification oligonucleotides for Neisseria species (United States Patent 5,747,252)
Vaccine against Neisseria meningitidis infections (United States Patent 5,618,541)
Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified state (United States Patent 5,618,540)
Method of producing Neisseria meningitidis B vaccine, and vaccine produced by method (United States Patent 5,597,572)
Method, reagents and kits for the detection of Neisseria gonorrhoeae (United States Patent 5,550,040)
Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae (United States Patent 5,536,638)
Support-bound nucletide probe for neisseria gonorrhoeae (United States Patent 5,525,717)
Oligonucleotides and methods for the detection of Neisseria gonorrhoeae (United States Patent 5,453,355)
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis (United States Patent 5,439,808)
Nucleic acid probes for the detection of Neisseria gonorrhoeae (United States Patent 5,432,271)
Vaccines against group C Neisseria meningitidis (United States Patent 5,425,946)
Isolated nucleotide sequences for identifying Neisseria gonorrhoeae (United States Patent 5,389,515)
Extraction procedure for Chlamydia and Neisseria antigens (United States Patent 5,387,511)
Specific detection of Neisseria gonorrhoeae (United States Patent 5,378,606)
Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations (United States Patent 5,286,484)
Nucleotide probe for Neisseria gonrrhoeae (United States Patent 5,256,536)
Method for the detection of Neisseria gonorrhoeae (United States Patent 5,217,862)
Detection of Neisseria gonorrohoeae (United States Patent 5,173,401)
Neisseria-specific DNA probe (United States Patent 5,162,199)
Host expressing NgoAIII restriction endonuclease and modification methylase from neisseria (United States Patent 5,147,800)
Nucleic acid probe for detection of Neisseria gonorrhoea (United States Patent 5,108,895)
Nucleic acid probe for detection of Neisseria gonorrhoea (United States Patent 5,099,011)
Neisseria detection system (United States Patent 5,089,394)
Nucleic acid probe for detection of neisseria gonorrhoea (United States Patent 5,047,523)
Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group (United States Patent 4,900,659)
Selective medium for growth of neisseria (United States Patent 4,814,276)
Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin (United States Patent 4,786,592)
Pili of neisseria and vaccine compositions containing same (United States Patent 4,769,240)
Paper strip assay for neisseria species (United States Patent 4,767,702)
Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae (United States Patent 4,696,896)
Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine (United States Patent 4,681,761)
Lectin-coated latex agglutination assay for Neisseria gonorrhoeae (United States Patent 4,659,658)
Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease (United States Patent 4,601,903)
Immunoassay for Neisseria gonorrhoeae antigens (United States Patent 4,497,900)
Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae (United States Patent 4,461,838)
Test method for the laboratory diagnosis of Gonorrhea and test strain of neisseria gonorrhoeae (United States Patent 4,446,230)
Neisseria gonorrhoeae vaccine (United States Patent 4,443,431)
Neisseria bacteria species identification and beta lactamase testing methods (United States Patent 4,390,622)
Purified antigen to test for Neisseria gonorrhoeae antibodies (United States Patent 4,351,761)
Detection of neisseria gonorrhoeae (United States Patent 4,332,890)
Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same (United States Patent 4,271,147)
Detecting Neisseria via immobilized antibody-enzyme complex (United States Patent 4,254,218)
Detection and quantitation of Neisseria via radioimmunoassay of an enzyme present in Neisseria bacteria (United States Patent 4,248,964)
Detection of Neisseria bacteria by immunoassay (United States Patent 4,245,038)
Purified antigen to test for Neisseria gonorrheae antibodies (United States Patent 4,241,045)
Neisseria gonorrhoeae vaccine (United States Patent 4,239,749)
Methods and media for rapid detection of pathogenic neisseria (United States Patent 4,229,530)
Method, reagents and apparatus for the rapid identification of Neisseria gonorrhoeae and Neisseria meningitidis (United States Patent 4,208,480)
Neisseria gonorrhoeae vaccine (United States Patent 4,203,971)
Immunological detection of Neisseria bacteria via labelled antibodies (United States Patent 4,188,371)
Serological test for Neisseria gonorrhoeae antibodies (United States Patent 4,186,182)
Detecting Neisseria bacteria (United States Patent 4,166,765)
Immunoassay of Neisseria bacteria via (NH.sub.4).sub.2 SO.sub.4 precipitation (United States Patent 4,140,581)
Identification of Neisseria gonorrhoeae (United States Patent 4,115,543)
Neisseria lactoferrin binding protein (United States Patent 7,105,316)
Method of treating subject infected with Neisseria gonorrhea (United States Patent 7,094,809)
Polynucleotides and polypeptides BASB033 from Neisseria meningitidis and their uses (United States Patent 7,071,321)
Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes (United States Patent 7,063,949)
Method of inhibiting formation of Neisseria gonorrhea and Neisseria meningiditis (United States Patent 7,037,945)
DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses (United States Patent 7,029,845)
Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies (United States Patent 6,994,860)
Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis (United States Patent 6,936,261)
Monoclonal antibody to the stabilizer peptide of the P64K antigen of Neisseria meningitidis (United States Patent 6,921,809)
Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria (United States Patent 6,861,507)
Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains (United States Patent 6,835,384)
Neisseria meningitidis antigen (United States Patent 6,797,273)
Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis (United States Patent 6,780,419)
Polypeptides and polynucleotides BASB040 from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides (United States Patent 6,770,284)
BASB013 DNA and proteins from Neisseria meningitidis (United States Patent 6,709,657)
BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof (United States Patent 6,696,062)
Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof (United States Patent 6,693,186)
Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes (United States Patent 6,642,354)
Neisseria meningitidis serogroup B Glycoconjugates (United States Patent 6,638,513)
Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses (United States Patent 6,627,204)
Nucleic acid molecules encoding proteins which impart the adhesion of neisseria cells to human cells (United States Patent 6,617,128)
OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof (United States Patent 6,610,306)
Hybridization assay probes and methods for detecting the presence of neisseria meningitiidis subtypes A, C and L in a sample (United States Patent 6,541,201)
Conjugate vaccine for Neisseria meningitidis (United States Patent 6,531,131)
Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus (United States Patent 6,497,880)
Invasion associated genes from Neisseria meningitidis serogroup B (United States Patent 6,472,518)
Transferrin receptor subunit proteins of Neisseria meningitidis (United States Patent 6,326,350)
Proteinase K resistant surface protein of neisseria meningitidis (United States Patent 6,287,574)
PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis (United States Patent 6,169,169)
Nucleic acid probes and amplification oligonucleotides for Neisseria species (United States Patent 6,100,027)
Neisseria gonorrhoeae-specific oligonucleotides (United States Patent 6,090,557)
Neisseria meningitidis capsular polysacchride conjugates (United States Patent 6,080,589)
Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis (United States Patent 6,028,049)
Hexapeptides of Neisseria gonorrhoeae (United States Patent 6,020,461)
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis (United States Patent 6,013,267)
Neisseria gonorrhoeae specific DNA fragment--GC3 (United States Patent 5,976,805)
Neisseria mutants, lipooligosaccharides and immunogenic compositions (United States Patent 5,976,536)
Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases (United States Patent 5,965,424)
Detection of Neisseria gonorrhoeae by amplification and detection of its nucleic acid (United States Patent 5,962,273)
Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified state (United States Patent 5,928,650)
Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis (United States Patent 5,912,336)
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis (United States Patent 5,879,686)
Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin (United States Patent 5,834,591)
Method of differentiating pelvic inflamatory disease and local isolates of Neisseria gonorrhoeae (United States Patent 5,824,480)
Neisseria meningitidis capsular polysaccharide conjugates (United States Patent 5,780,606)
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis (United States Patent 5,747,287)
Nucleic acid probes and amplification oligonucleotides for Neisseria species (United States Patent 5,747,252)
Vaccine against Neisseria meningitidis infections (United States Patent 5,618,541)
Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified state (United States Patent 5,618,540)
Method of producing Neisseria meningitidis B vaccine, and vaccine produced by method (United States Patent 5,597,572)
Method, reagents and kits for the detection of Neisseria gonorrhoeae (United States Patent 5,550,040)
Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae (United States Patent 5,536,638)
Support-bound nucletide probe for neisseria gonorrhoeae (United States Patent 5,525,717)
Oligonucleotides and methods for the detection of Neisseria gonorrhoeae (United States Patent 5,453,355)
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis (United States Patent 5,439,808)
Nucleic acid probes for the detection of Neisseria gonorrhoeae (United States Patent 5,432,271)
Vaccines against group C Neisseria meningitidis (United States Patent 5,425,946)
Isolated nucleotide sequences for identifying Neisseria gonorrhoeae (United States Patent 5,389,515)
Extraction procedure for Chlamydia and Neisseria antigens (United States Patent 5,387,511)
Specific detection of Neisseria gonorrhoeae (United States Patent 5,378,606)
Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations (United States Patent 5,286,484)
Nucleotide probe for Neisseria gonrrhoeae (United States Patent 5,256,536)
Method for the detection of Neisseria gonorrhoeae (United States Patent 5,217,862)
Detection of Neisseria gonorrohoeae (United States Patent 5,173,401)
Neisseria-specific DNA probe (United States Patent 5,162,199)
Host expressing NgoAIII restriction endonuclease and modification methylase from neisseria (United States Patent 5,147,800)
Nucleic acid probe for detection of Neisseria gonorrhoea (United States Patent 5,108,895)
Nucleic acid probe for detection of Neisseria gonorrhoea (United States Patent 5,099,011)
Neisseria detection system (United States Patent 5,089,394)
Nucleic acid probe for detection of neisseria gonorrhoea (United States Patent 5,047,523)
Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group (United States Patent 4,900,659)
Selective medium for growth of neisseria (United States Patent 4,814,276)
Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin (United States Patent 4,786,592)
Pili of neisseria and vaccine compositions containing same (United States Patent 4,769,240)
Paper strip assay for neisseria species (United States Patent 4,767,702)
Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae (United States Patent 4,696,896)
Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine (United States Patent 4,681,761)
Lectin-coated latex agglutination assay for Neisseria gonorrhoeae (United States Patent 4,659,658)
Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease (United States Patent 4,601,903)
Immunoassay for Neisseria gonorrhoeae antigens (United States Patent 4,497,900)
Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae (United States Patent 4,461,838)
Test method for the laboratory diagnosis of Gonorrhea and test strain of neisseria gonorrhoeae (United States Patent 4,446,230)
Neisseria gonorrhoeae vaccine (United States Patent 4,443,431)
Neisseria bacteria species identification and beta lactamase testing methods (United States Patent 4,390,622)
Purified antigen to test for Neisseria gonorrhoeae antibodies (United States Patent 4,351,761)
Detection of neisseria gonorrhoeae (United States Patent 4,332,890)
Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same (United States Patent 4,271,147)
Detecting Neisseria via immobilized antibody-enzyme complex (United States Patent 4,254,218)
Detection and quantitation of Neisseria via radioimmunoassay of an enzyme present in Neisseria bacteria (United States Patent 4,248,964)
Detection of Neisseria bacteria by immunoassay (United States Patent 4,245,038)
Purified antigen to test for Neisseria gonorrheae antibodies (United States Patent 4,241,045)
Neisseria gonorrhoeae vaccine (United States Patent 4,239,749)
Methods and media for rapid detection of pathogenic neisseria (United States Patent 4,229,530)
Method, reagents and apparatus for the rapid identification of Neisseria gonorrhoeae and Neisseria meningitidis (United States Patent 4,208,480)
Neisseria gonorrhoeae vaccine (United States Patent 4,203,971)
Immunological detection of Neisseria bacteria via labelled antibodies (United States Patent 4,188,371)
Serological test for Neisseria gonorrhoeae antibodies (United States Patent 4,186,182)
Detecting Neisseria bacteria (United States Patent 4,166,765)
Immunoassay of Neisseria bacteria via (NH.sub.4).sub.2 SO.sub.4 precipitation (United States Patent 4,140,581)
Identification of Neisseria gonorrhoeae (United States Patent 4,115,543)

Although his recognition as a registered patent agent permits him to represent others in all patent matters before the United States Patent and Trademark Office, Dr. Demchick limits his practice to patent matters involving inventions for which he is confident that his expertise will allow him to serve his client well. He will gladly discuss whether he is comfortable handling cases involving inventions in a particular field. He will err on the side of declining cases if he has uncertainty about his ability to do what is needed in the case. Dr. Demchick does not represent clients in court. However, he refers clients to a patent attorney who does represent others in court, if it appears likely that patent related representation in court is appropriate. Dr. Demchick prepares and files non-provisional (regular) patent applications and provisional patent applications. He prepares and files utility patent applications and design patent applications. He prepares and files U.S. patent applications and international patent applications under the Patent Cooperation Treaty (PCT). He prepares and files applications to enter the U.S. National Phase for inventions for which international patent applications (PCT) were already filed. One of the matters he discusses with each client or potential client is which type of application(s) best meets that client's needs. He usually does a patent search (patentability search) as part of the preparation of a patent application. He discusses the value of patent searching with each inventor before agreeing to prepare a patent application for that inventor.